PR-VR At-home Program During and After COVID-19
Pain Rehabilitation Virtual Reality (PR-VR) At-home Program: A Pilot Randomized Controlled Trial to Determine Feasibility and Impact on Pain and Function in Adolescents During and After COVID-19
1 other identifier
interventional
40
1 country
1
Brief Summary
Poorly controlled chronic pain in teens can impact quality of life, increase opioid use and is a risk factor for developing chronic pain in adulthood. Currently, there is a shortage of support to help teens manage chronic pain in the community and the support that did exist has been significantly scaled back due to the COVID-19 pandemic. This research study will investigate, based on questionnaires with teens and healthcare providers and interviews with teens, whether pain rehabilitation virtual reality is easy to use and understand, satisfactory to use, and whether it may improve pain, mobility, and function for the teens using the program compared to those doing standard physiotherapy treatment over videoconference.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 31, 2021
CompletedFirst Posted
Study publicly available on registry
June 3, 2021
CompletedStudy Start
First participant enrolled
September 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 6, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 6, 2024
CompletedJuly 9, 2025
July 1, 2025
2.3 years
May 31, 2021
July 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Participant Accrual
PR-VR Recruitment Log has been designed to measure accrual rates (i.e., record data related to the number of eligible adolescents per recruitment day, reasons for ineligibility, and reasons for non-participation)
1 year
Participant Engagement
PR-VR Activity Log has been designed to measure participant engagement in the study (i.e., record data related to number of completed sessions as well as independent PT exercise sessions participants self-report completing in between clinician-led sessions)
1 year
Participant Retention
PR-VR Activity Log has been designed to measure retention rates (i.e., record data related to reasons for study attrition)
1 year
Technical Issues
PR-VR Intervention Log has been designed to record data related to technical and practical issues (occurrence and description) associated with the PR-VR intervention and implementation of the trial protocol, and time to set up and conduct PR-VR as well as any adverse events (e.g. dizziness, nausea) including the date and time the event occurred and the nature of the event.
1 year
Safety of PR-VR Program
PR-VR Intervention Log has been designed to record data related to any adverse events (e.g. dizziness, nausea) including the date and time the event occurred and the nature of the event.
1 year
Time
PR-VR Intervention Log has been designed to record data related to time to set up
1 year
Acceptability/Satisfaction
Measured using the PR-VR Satisfaction Questionnaire completed by adolescent participants and PTs (using adolescent- and PT-specific versions). This questionnaire will collect data on acceptability and perceived utility of PR-VR intervention. Child questionnaire = Scores range from 1-4 (4-pt likert scale), higher scores indicate greater degree of acceptance (better). PT questionnaire = Scores range from 0-4 (5 pt likert scale), each question has different anchors, so better/worse depends on the question
1 year
Outcome measure feasibility
Will be measured as the percentage of completed outcome measures at baseline and study completion and will be recorded on the PR-VR Distraction Activity Log
1 year
Secondary Outcomes (11)
Fear of movement
Collected at baseline (T1) and 4 weeks from baseline (T2)
Pain self-efficacy
Collected at baseline (T1) and 4 weeks from baseline (T2)
Pain catastrophizing
Collected at baseline (T1) and 4 weeks from baseline (T2)
Pain intensity
Collected at baseline (T1), and immediately post- each PT session verbally to the PT, and 4 weeks from baseline (T2)
Presence/immersiveness
Post- each PT session, through study completion, an average of 1 year
- +6 more secondary outcomes
Study Arms (3)
Off the Shelf VR (PR-VR program + usual care)
EXPERIMENTAL* One session per week x 4 weeks; total 4 sessions over 1 month * PR-VR program (30 min) + Usual care (30 min SVPT) * Total intervention time = 4 hours * 10 selected for post-study telephone interview
Custom VR (Modified PR-VR program + usual care)
EXPERIMENTAL* One session per week x 4 weeks; total 4 sessions over 1 month * Mod PR-VR program (30 min) + Usual care (30 min SVPT) * Total intervention time = 4 hours * 10 selected for post-study telephone interview
Standard Virtual Physiotherapy Treatment (control; usual care),
NO INTERVENTION* One session per week x 4 weeks; total 4 sessions over 1 month * Usual care (60 min SVPT) * Total intervention time = 4 hours
Interventions
Operates using Oculus quest VR HMD and uses auditory and visual stimuli during the pain rehabilitation treatment. The Off-the-shelf VR program for Oculus Quest VR features a suite of "off-the shelf" applications that can be tailored by the PT and used with participants including. PR-VR sessions will be 30 minutes in total with approximately 20 minutes in the virtual experience and 10 minutes for set-up, screening, instructions, and rest breaks. The Off-the-shelf VR intervention group will also receive 30 minutes of usual care, and Standard Virtual Physiotherapy Treatment (SVPT) during the same appointment, for a total 1-hour usual care session length.
Operates using Oculus Quest VR HMD with PR-VR software developed with two gaming options: Fruity Feet and Space Burgers 2. Game settings are manipulated by the physiotherapist in session to target specific limb movements and intensity and also motivates participants to cycle using a leg ergometer. Motion sensors on the ergometer track the participants revolutions per minute. For participants in this study arm, a leg ergometer (DeskCycle) will be provided to them during the study phase alongside the Actigraph and Oculus Quest HMD. During the 30min VR portion of the session, 20 minutes will be dedicated to gaming and exercise, and 10 minutes dedicated for set up, tear down, and rest breaks. During the 20 minutes gaming time, a minimum of 15 minutes will be dedicated to Custom VR, with 5 minutes for 'free play' where the participant can opt to try an off-the-shelf VR game.
Eligibility Criteria
You may qualify if:
- able to speak and read English,
- years old,
- diagnosed with chronic pain,
- under active care at the interprofessional out-patient Chronic Pain Clinic at SickKids,
- on stabilized medication/therapy (no new pain medications/therapies for 1 week prior to the initial PT assessment and treatment) according to medical chart,
- independently mobile and able to safely engage in physical activity,
- requiring a minimum of 4 treatments (1-hour sessions of virtual PT) typically once per week,
- able to have access to an Internet-enabled smartphone, computer or tablet at home (typically once per week for 4 weeks) according to self-report for Zoom for Healthcare visits with PT, and
- willing to have Zoom for Healthcare visits with PT recorded during the study period and, if selected, individual telephone interview with research assistant (RA) audio recorded following the study period.
You may not qualify if:
- visual, auditory or cognitive impairments precluding interaction with the PR-VR intervention and/or control equipment (Internet) as assessed by reviewing the patient's medical chart and consultation with the patient's PT.
- diagnosis of seizure disorder, history of seizure, or increased risk of seizure.
- new onset of headaches/migraines, motion sickness, nausea or vomiting or history/symptoms of possible concussion.
- diagnosis of major, untreated, concurrent psychiatric illness (e.g., depression, anxiety, conversion disorder, PTSD) or personality disorder as assessed by reviewing the patient's medical chart and in consultation by their health care team.
- currently receiving sedating medications
- claustrophobia or previous intolerance of virtual reality (e.g. nausea, vomiting, motion sickness, eye strain, false memory formation) as assessed by health care team.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Hospital for Sick Childrenlead
- Stanford Universitycollaborator
Study Sites (1)
Hospital for Sick Children
Toronto, Ontario, m5g 1x8, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer Stinson, RN, PhD
The Hospital for Sick Children
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Scientist
Study Record Dates
First Submitted
May 31, 2021
First Posted
June 3, 2021
Study Start
September 1, 2022
Primary Completion
December 6, 2024
Study Completion
December 6, 2024
Last Updated
July 9, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share